GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Construction In Progress

Alkem Laboratories (NSE:ALKEM) Construction In Progress : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Construction In Progress?

Alkem Laboratories's quarterly construction in progress increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹1,808 Mil) but then declined from Sep. 2023 (₹1,808 Mil) to Dec. 2023 (₹0 Mil).

Alkem Laboratories's annual construction in progress declined from Mar. 2021 (₹3,933 Mil) to Mar. 2022 (₹3,395 Mil) and declined from Mar. 2022 (₹3,395 Mil) to Mar. 2023 (₹3,103 Mil).


Alkem Laboratories Construction In Progress Historical Data

The historical data trend for Alkem Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Construction In Progress Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,929.60 3,629.70 3,932.80 3,394.80 3,102.70

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,102.70 - 1,808.20 -

Alkem Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines